COVID-19 Impact on Global Recombinant Antibody Market Size, Status and Forecast 2020-2026

September 2020 | 96 pages | ID: CAB672C3CA68EN
QYResearch

Abstracts

This report focuses on the global Recombinant Antibody status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Recombinant Antibody development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Abnova
• Medix Biochemica
• GE Healthcare
• SinoBiological
• Bioventix

Market segment by Type, the product can be split into

• Chimeric Antibody
• Humanized Antibody
• Full Human Antibody
• Single Chain Antibody
• Bispecific Antibody

Market segment by Application, split into

• Hospital
• Scientific Research
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Recombinant Antibody status, future forecast, growth opportunity, key market and key players.
• To present the Recombinant Antibody development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Recombinant Antibody are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Recombinant Antibody Revenue
1.4 Market Analysis by Type
  1.4.1 Global Recombinant Antibody Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Chimeric Antibody
  1.4.3 Humanized Antibody
  1.4.4 Full Human Antibody
  1.4.5 Single Chain Antibody
  1.4.6 Bispecific Antibody
1.5 Market by Application
  1.5.1 Global Recombinant Antibody Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Scientific Research
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Recombinant Antibody Industry Impact
  1.6.1 How the Covid-19 is Affecting the Recombinant Antibody Industry
    1.6.1.1 Recombinant Antibody Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Recombinant Antibody Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Recombinant Antibody Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Recombinant Antibody Market Perspective (2015-2026)
2.2 Recombinant Antibody Growth Trends by Regions
  2.2.1 Recombinant Antibody Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Recombinant Antibody Historic Market Share by Regions (2015-2020)
  2.2.3 Recombinant Antibody Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Recombinant Antibody Market Growth Strategy
  2.3.6 Primary Interviews with Key Recombinant Antibody Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Recombinant Antibody Players by Market Size
  3.1.1 Global Top Recombinant Antibody Players by Revenue (2015-2020)
  3.1.2 Global Recombinant Antibody Revenue Market Share by Players (2015-2020)
  3.1.3 Global Recombinant Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Recombinant Antibody Market Concentration Ratio
  3.2.1 Global Recombinant Antibody Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Recombinant Antibody Revenue in 2019
3.3 Recombinant Antibody Key Players Head office and Area Served
3.4 Key Players Recombinant Antibody Product Solution and Service
3.5 Date of Enter into Recombinant Antibody Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Recombinant Antibody Historic Market Size by Type (2015-2020)
4.2 Global Recombinant Antibody Forecasted Market Size by Type (2021-2026)

5 RECOMBINANT ANTIBODY BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Recombinant Antibody Market Size by Application (2015-2020)
5.2 Global Recombinant Antibody Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Recombinant Antibody Market Size (2015-2020)
6.2 Recombinant Antibody Key Players in North America (2019-2020)
6.3 North America Recombinant Antibody Market Size by Type (2015-2020)
6.4 North America Recombinant Antibody Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Recombinant Antibody Market Size (2015-2020)
7.2 Recombinant Antibody Key Players in Europe (2019-2020)
7.3 Europe Recombinant Antibody Market Size by Type (2015-2020)
7.4 Europe Recombinant Antibody Market Size by Application (2015-2020)

8 CHINA

8.1 China Recombinant Antibody Market Size (2015-2020)
8.2 Recombinant Antibody Key Players in China (2019-2020)
8.3 China Recombinant Antibody Market Size by Type (2015-2020)
8.4 China Recombinant Antibody Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Recombinant Antibody Market Size (2015-2020)
9.2 Recombinant Antibody Key Players in Japan (2019-2020)
9.3 Japan Recombinant Antibody Market Size by Type (2015-2020)
9.4 Japan Recombinant Antibody Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Recombinant Antibody Market Size (2015-2020)
10.2 Recombinant Antibody Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Recombinant Antibody Market Size by Type (2015-2020)
10.4 Southeast Asia Recombinant Antibody Market Size by Application (2015-2020)

11 INDIA

11.1 India Recombinant Antibody Market Size (2015-2020)
11.2 Recombinant Antibody Key Players in India (2019-2020)
11.3 India Recombinant Antibody Market Size by Type (2015-2020)
11.4 India Recombinant Antibody Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Recombinant Antibody Market Size (2015-2020)
12.2 Recombinant Antibody Key Players in Central & South America (2019-2020)
12.3 Central & South America Recombinant Antibody Market Size by Type (2015-2020)
12.4 Central & South America Recombinant Antibody Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Abnova
  13.1.1 Abnova Company Details
  13.1.2 Abnova Business Overview and Its Total Revenue
  13.1.3 Abnova Recombinant Antibody Introduction
  13.1.4 Abnova Revenue in Recombinant Antibody Business (2015-2020))
  13.1.5 Abnova Recent Development
13.2 Medix Biochemica
  13.2.1 Medix Biochemica Company Details
  13.2.2 Medix Biochemica Business Overview and Its Total Revenue
  13.2.3 Medix Biochemica Recombinant Antibody Introduction
  13.2.4 Medix Biochemica Revenue in Recombinant Antibody Business (2015-2020)
  13.2.5 Medix Biochemica Recent Development
13.3 GE Healthcare
  13.3.1 GE Healthcare Company Details
  13.3.2 GE Healthcare Business Overview and Its Total Revenue
  13.3.3 GE Healthcare Recombinant Antibody Introduction
  13.3.4 GE Healthcare Revenue in Recombinant Antibody Business (2015-2020)
  13.3.5 GE Healthcare Recent Development
13.4 SinoBiological
  13.4.1 SinoBiological Company Details
  13.4.2 SinoBiological Business Overview and Its Total Revenue
  13.4.3 SinoBiological Recombinant Antibody Introduction
  13.4.4 SinoBiological Revenue in Recombinant Antibody Business (2015-2020)
  13.4.5 SinoBiological Recent Development
13.5 Bioventix
  13.5.1 Bioventix Company Details
  13.5.2 Bioventix Business Overview and Its Total Revenue
  13.5.3 Bioventix Recombinant Antibody Introduction
  13.5.4 Bioventix Revenue in Recombinant Antibody Business (2015-2020)
  13.5.5 Bioventix Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Recombinant Antibody Key Market Segments
Table 2. Key Players Covered: Ranking by Recombinant Antibody Revenue
Table 3. Ranking of Global Top Recombinant Antibody Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Recombinant Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chimeric Antibody
Table 6. Key Players of Humanized Antibody
Table 7. Key Players of Full Human Antibody
Table 8. Key Players of Single Chain Antibody
Table 9. Key Players of Bispecific Antibody
Table 10. COVID-19 Impact Global Market: (Four Recombinant Antibody Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Recombinant Antibody Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Recombinant Antibody Players to Combat Covid-19 Impact
Table 15. Global Recombinant Antibody Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Recombinant Antibody Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Recombinant Antibody Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Recombinant Antibody Market Share by Regions (2015-2020)
Table 19. Global Recombinant Antibody Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Recombinant Antibody Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Recombinant Antibody Market Growth Strategy
Table 25. Main Points Interviewed from Key Recombinant Antibody Players
Table 26. Global Recombinant Antibody Revenue by Players (2015-2020) (Million US$)
Table 27. Global Recombinant Antibody Market Share by Players (2015-2020)
Table 28. Global Top Recombinant Antibody Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Antibody as of 2019)
Table 29. Global Recombinant Antibody by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Recombinant Antibody Product Solution and Service
Table 32. Date of Enter into Recombinant Antibody Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Recombinant Antibody Market Size by Type (2015-2020) (Million US$)
Table 35. Global Recombinant Antibody Market Size Share by Type (2015-2020)
Table 36. Global Recombinant Antibody Revenue Market Share by Type (2021-2026)
Table 37. Global Recombinant Antibody Market Size Share by Application (2015-2020)
Table 38. Global Recombinant Antibody Market Size by Application (2015-2020) (Million US$)
Table 39. Global Recombinant Antibody Market Size Share by Application (2021-2026)
Table 40. North America Key Players Recombinant Antibody Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Recombinant Antibody Market Share (2019-2020)
Table 42. North America Recombinant Antibody Market Size by Type (2015-2020) (Million US$)
Table 43. North America Recombinant Antibody Market Share by Type (2015-2020)
Table 44. North America Recombinant Antibody Market Size by Application (2015-2020) (Million US$)
Table 45. North America Recombinant Antibody Market Share by Application (2015-2020)
Table 46. Europe Key Players Recombinant Antibody Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Recombinant Antibody Market Share (2019-2020)
Table 48. Europe Recombinant Antibody Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Recombinant Antibody Market Share by Type (2015-2020)
Table 50. Europe Recombinant Antibody Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Recombinant Antibody Market Share by Application (2015-2020)
Table 52. China Key Players Recombinant Antibody Revenue (2019-2020) (Million US$)
Table 53. China Key Players Recombinant Antibody Market Share (2019-2020)
Table 54. China Recombinant Antibody Market Size by Type (2015-2020) (Million US$)
Table 55. China Recombinant Antibody Market Share by Type (2015-2020)
Table 56. China Recombinant Antibody Market Size by Application (2015-2020) (Million US$)
Table 57. China Recombinant Antibody Market Share by Application (2015-2020)
Table 58. Japan Key Players Recombinant Antibody Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Recombinant Antibody Market Share (2019-2020)
Table 60. Japan Recombinant Antibody Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Recombinant Antibody Market Share by Type (2015-2020)
Table 62. Japan Recombinant Antibody Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Recombinant Antibody Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Recombinant Antibody Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Recombinant Antibody Market Share (2019-2020)
Table 66. Southeast Asia Recombinant Antibody Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Recombinant Antibody Market Share by Type (2015-2020)
Table 68. Southeast Asia Recombinant Antibody Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Recombinant Antibody Market Share by Application (2015-2020)
Table 70. India Key Players Recombinant Antibody Revenue (2019-2020) (Million US$)
Table 71. India Key Players Recombinant Antibody Market Share (2019-2020)
Table 72. India Recombinant Antibody Market Size by Type (2015-2020) (Million US$)
Table 73. India Recombinant Antibody Market Share by Type (2015-2020)
Table 74. India Recombinant Antibody Market Size by Application (2015-2020) (Million US$)
Table 75. India Recombinant Antibody Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Recombinant Antibody Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Recombinant Antibody Market Share (2019-2020)
Table 78. Central & South America Recombinant Antibody Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Recombinant Antibody Market Share by Type (2015-2020)
Table 80. Central & South America Recombinant Antibody Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Recombinant Antibody Market Share by Application (2015-2020)
Table 82. Abnova Company Details
Table 83. Abnova Business Overview
Table 84. Abnova Product
Table 85. Abnova Revenue in Recombinant Antibody Business (2015-2020) (Million US$)
Table 86. Abnova Recent Development
Table 87. Medix Biochemica Company Details
Table 88. Medix Biochemica Business Overview
Table 89. Medix Biochemica Product
Table 90. Medix Biochemica Revenue in Recombinant Antibody Business (2015-2020) (Million US$)
Table 91. Medix Biochemica Recent Development
Table 92. GE Healthcare Company Details
Table 93. GE Healthcare Business Overview
Table 94. GE Healthcare Product
Table 95. GE Healthcare Revenue in Recombinant Antibody Business (2015-2020) (Million US$)
Table 96. GE Healthcare Recent Development
Table 97. SinoBiological Company Details
Table 98. SinoBiological Business Overview
Table 99. SinoBiological Product
Table 100. SinoBiological Revenue in Recombinant Antibody Business (2015-2020) (Million US$)
Table 101. SinoBiological Recent Development
Table 102. Bioventix Company Details
Table 103. Bioventix Business Overview
Table 104. Bioventix Product
Table 105. Bioventix Revenue in Recombinant Antibody Business (2015-2020) (Million US$)
Table 106. Bioventix Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Recombinant Antibody Market Share by Type: 2020 VS 2026
Figure 2. Chimeric Antibody Features
Figure 3. Humanized Antibody Features
Figure 4. Full Human Antibody Features
Figure 5. Single Chain Antibody Features
Figure 6. Bispecific Antibody Features
Figure 7. Global Recombinant Antibody Market Share by Application: 2020 VS 2026
Figure 8. Hospital Case Studies
Figure 9. Scientific Research Case Studies
Figure 10. Others Case Studies
Figure 11. Recombinant Antibody Report Years Considered
Figure 12. Global Recombinant Antibody Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Recombinant Antibody Market Share by Regions: 2020 VS 2026
Figure 14. Global Recombinant Antibody Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Recombinant Antibody Market Share by Players in 2019
Figure 17. Global Top Recombinant Antibody Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Antibody as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Recombinant Antibody Revenue in 2019
Figure 19. North America Recombinant Antibody Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Recombinant Antibody Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Recombinant Antibody Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Recombinant Antibody Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Recombinant Antibody Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Recombinant Antibody Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Recombinant Antibody Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Abnova Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Abnova Revenue Growth Rate in Recombinant Antibody Business (2015-2020)
Figure 28. Medix Biochemica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Medix Biochemica Revenue Growth Rate in Recombinant Antibody Business (2015-2020)
Figure 30. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. GE Healthcare Revenue Growth Rate in Recombinant Antibody Business (2015-2020)
Figure 32. SinoBiological Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. SinoBiological Revenue Growth Rate in Recombinant Antibody Business (2015-2020)
Figure 34. Bioventix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Bioventix Revenue Growth Rate in Recombinant Antibody Business (2015-2020)
Figure 36. Bottom-up and Top-down Approaches for This Report
Figure 37. Data Triangulation
Figure 38. Key Executives Interviewed